• Home
  • Covaxin Human Trials

COVAXIN HUMAN TRIALS

Covaxin COVID-19 Vaccine Shows 77.8% Overall Efficacy, 65.2% Protection Against Delta Variant, Claims Bharat Biotech in Results From Phase 3 Clinical Trials
News

Covaxin COVID-19 Vaccine Shows 77.8% Overall Efficacy, 65.2% Protection Against Delta Variant, Claims Bharat Biotech in Results From Phase 3 Clinical Trials
Covaxin Trial Update: Human Trials For Bharat Biotech's Indigenous COVID-19 Vaccine Begins at Chennai's SRM Hospital
Health & Wellness

Covaxin Trial Update: Human Trials For Bharat Biotech's Indigenous COVID-19 Vaccine Begins at Chennai's SRM Hospital
COVAXIN Human Trials Begin in Haryana, State Health Minister Anil Vij Claims Vaccine Has No Adverse Effects
Health & Wellness

COVAXIN Human Trials Begin in Haryana, State Health Minister Anil Vij Claims Vaccine Has No Adverse Effects

Short Videos
Google Trends Google Trends
Today's Trends

Editor's Choice

Trending Topics
The Summer I Turned PrettySharad Navratri 2025Fact CheckShah Rukh KhanDonald TrumpViral VideosAsia Cup 2025Bigg Boss 19Rahul GandhiWeather Forecast TodayNarendra ModiBihar Assembly Elections 2025Kerala Lottery Results
Close